Johanna Stoevesandt

Over- and underestimated parameters in severe Hymenoptera venom–induced anaphylaxis: Cardiovascular medication and absence of urticaria/angioedema

Johanna Stoevesandt, Johannes Hain, Andreas Kerstan et al. · Journal of Allergy and Clinical Immunology · 2012 · 113 citations

Allergy, Medicine, Pharmacology +9

Treatment of pemphigus vulgaris and foliaceus with efgartigimod, a neonatal Fc receptor inhibitor: a phase II multicentre, open‐label feasibility trial*

Matthias Goebeler, Zsuzsanna Bata‐Csörgõ, Clara De Simone et al. · British Journal of Dermatology · 2021 · 95 citations · Full text

Radiocontrast Media Hypersensitivity: Skin Testing Differentiates Allergy From Nonallergic Reactions and Identifies a Safe Alternative as Proven by Intravenous Provocation

Axel Trautmann, Knut Brockow, Valeria Behle et al. · The Journal of Allergy and Clinical Immunology In Practice · 2019 · 69 citations

Drug Hypersensitivity, Intravenous Provocation, Allergy +11

Angiotensin‐converting enzyme inhibitors do not impair the safety of Hymenoptera venom immunotherapy build‐up phase

Johanna Stoevesandt, Johannes Hain, Ina Stolze et al. · Clinical & Experimental Allergy · 2014 · 61 citations

Comprehensive Mutation Scanning of NF1 in Apparently Sporadic Cases of Pheochromocytoma

Birke Bausch, Ann-Cathrin Koschker, Johanna Stoevesandt et al. · The Journal of Clinical Endocrinology & Metabolism · 2006 · 59 citations · Full text